Tarsus Pharmaceuticals, Inc. TARS Deferred Tax Assets, Net
Deferred Tax Assets, Net at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsLiabilitiesNet.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s deferred tax assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s deferred tax assets, net?
- Tarsus Pharmaceuticals, Inc. (TARS) reported deferred tax assets, net of $0 in Q4 2025.